TPL2 enforces RAS-induced inflammatory signaling and is activated by point mutations is a research paper published in Journal of Clinical Investigation (2020). On theSindex it has a DataRank of 0. It has been cited 33 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R37CA219697-01
American Cancer Society
Grant: RSG-17-203-01-TBG
National Institutes of Health
Grant: 1P50CA196510-01A1
Washington University SPORE in Pancreatic Cancer
National Institutes of Health
Grant: P50CA196510
NIDDK NIH HHS
Grant: P30 DK052574
NCI NIH HHS
Grant: R21 CA223112
NCI NIH HHS
Grant: P30 CA016672
NCI NIH HHS
Grant: R37 CA219697
NCI NIH HHS
Grant: U54 CA224083
National Institutes of Health
Grant: 1P30DK052574-01A1
Core--Transgenic mouse and stem cell
National Institutes of Health
Grant: 5R37CA219697-05
IRAK4 As a Novel Immunotherapeutic Target in Pancreatic Ductal Adenocarcinoma
FWCI
1.42
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals